French give go-ahead to biosimilar substitution
This article was originally published in Scrip
Executive Summary
In an audacious move that could have knock-on effects elsewhere in Europe, the French parliament has approved a measure allowing pharmacists to substitute a biosimilar for an originator biological medicine in certain cases.